We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Hears Arguments In Kubin Biotech Case

Law360 (January 8, 2009, 12:00 AM EST) -- In a case that is being closely watched by the biotechnology industry, a federal appeals court heard oral arguments Thursday in In re Kubin, which challenges a decision that upheld the rejection of Amgen Inc. scientists’ patent application for claims related to preparing a cDNA molecule encoding a particular protein.

The scientists are contesting the Board of Patent Appeals and Interferences’ ruling in May 2007 that affirmed an examiner’s rejection of the claims due to obviousness and failure to meet the written description requirement. The three-judge...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.